2006 ARCHIVAL NEWS CONTENT
Rights granted for reproduction by any legitimate news organization. However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. Information is believed accurate, as provided by news source or authorized agency, however is not guaranteed, and you assume all risk for use of any information found herein/hereupon. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
Local Reads as of 2018-01-16 16:47:03: 766 views
REFERENCES:California Business News, Philippine Bureau of Food and Drugs, BFAD, approved, Expanded Access Program for Rexin-G, FDA, treatment of all solid tumors and metastatic cancer, Dr. Erlinda Maria Gordon, M.D., Pathotropic (or disease-seeking) Medicine, FDA Orphan Drug status, San Marino, California Epeius Biotechnologies Corporation